Lexeo Therapeutics to Participate in Upcoming Investor Conferences
2024年5月7日 - 8:30PM
Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic
medicine company dedicated to pioneering treatments for genetically
defined cardiovascular diseases and APOE4-associated Alzheimer’s
disease, today announced that company management will participate
in fireside chats at the following investor conferences:
The Citizens JMP Life Sciences
Conference on Monday, May 13, 2024 at 9:00 AM ETRBC Capital Markets
2024 Global Healthcare Conference on Tuesday, May 14, 2024 at 11:00
AM ETBank of America Securities 2024 Health Care Conference on
Wednesday, May 15, 2024 at 8:40 AM PT
The events will be webcast live under the News & Events tab
in the Investors section of our website. Replays of the webcasts
will be available on the website following the presentations.
About Lexeo TherapeuticsLexeo Therapeutics is a
New York City-based, clinical stage genetic medicine company
dedicated to transforming healthcare by applying pioneering science
to fundamentally change how genetically defined cardiovascular
diseases and APOE4-associated Alzheimer’s disease are treated.
Using a stepwise development approach, Lexeo is leveraging early
proof-of-concept functional and biomarker data to advance a
pipeline of cardiovascular and APOE4-associated Alzheimer’s disease
programs.
Media Response:Janine Bogris(201)
245-6838janine.bogris@inizioevoke.com
Investor Response:Stephen Jasper(858)
525-2047stephen@gilmartinir.com
Lexeo Therapeutics (NASDAQ:LXEO)
過去 株価チャート
から 4 2024 まで 5 2024
Lexeo Therapeutics (NASDAQ:LXEO)
過去 株価チャート
から 5 2023 まで 5 2024
